Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician
Determining the optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention is a complex decision. Randomized controlled trials have shown that while shorter durations of DAPT may lower the risk of bleeding, longer durations of DAPT can reduce the risk of late stent thrombosis and ischemia-related events. In this review article, we will discuss the current guidelines, review contemporary trial data that have evaluated short and extended durations of DAPT, and address common clinical questions.
Source: Progress in Cardiovascular Diseases - Category: Cardiology Authors: Mahesh K. Vidula, Eric A. Secemsky, Robert W. Yeh Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Thrombosis